Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Translational Oncology|August 2, 2011
Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric OncologyEddy Pasquier, Mark W Kieran, Jaroslav Sterba, et al.
Journal of Clinical Medicine|March 11, 2023
Initial Evidence for Positive Effects of a Psychological Preparation Program for MRI "iMReady" in Children with Neurofibromatosis Type I and Brain Tumors-How to Meet the Patients' Needs BestLiesa Josephine Weiler-Wichtl, Jonathan Fries, Verena Fohn-Erhold, et al.
Klinische Padiatrie|July 26, 2023
Bridging the gap: A quality improvement project to implement psychosocial care standards into clinical practice in pediatric oncologyLiesa J Weiler-Wichtl, Verena Fohn-Erhold, Carina Schneider, et al.
Cancers|October 27, 2022
Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a "MEMMAT-like" Metronomic Antiangiogenic ApproachIrene Slavc, Lisa Mayr, Natalia Stepien, et al.
Pediatric Blood & Cancer|August 4, 2017
Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [<sup>18</sup> F]FDG-PET imaging. Is it of value in asymptomatic patients?Amedeo A Azizi, Irene Slavc, Benjamin Emile Theisen, et al.
Neuro-Oncology Advances|April 28, 2026
Impact of Bevacizumab treatment intervals on surgical interventions in pediatric neuro-oncologyHannah Schned, Maria Aliotti Lippolis, Cora Hedrich, et al.
Frontiers in Oncology|July 25, 2024
Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngiomaCora Hedrich, Priya Patel, Lukas Haider, et al.
Cancers|May 13, 2023
Proof-of-Concept for Liquid Biopsy Disease Monitoring of <i>MYC</i>-Amplified Group 3 Medulloblastoma by Droplet Digital PCRNatalia Stepien, Daniel Senfter, Julia Furtner, et al.
Acta Neuropathologica Communications|August 9, 2019
TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAF<sup>V600E</sup>/TERT promoter double-mutated gliomaLisa Gabler, Daniela Lötsch, Dominik Kirchhofer, et al.
Neuro-Oncology|June 3, 2026
Final report of the SIOP-CNS-GCT II protocol for germinoma-omitting radiotherapy boost is safe in localized disease in complete remission after chemotherapyGabriele Calaminus, Claire Alapetite, Rolf D Kortmann, et al.
Pageof 8